NEW SMYRNA BEACH, Fla., June 9, 2017 On May 23, Florida Hospital New Smyrna received $5,000 from the Best Western New Smyrna Beach Hotel and Suites.
This donation will be used to improve the health initiatives provided by the 112-bed facility in Southeast Volusia County.
We are very appreciative of the Best Western for their donation, said Craig Bair, Florida Hospital New Smyrna Foundation president. New Smyrna Beach is a truly amazing community of businesses and citizens who recognize the hospital is a community asset and donate to support it.
About Florida Hospital New Smyrna
Florida Hospital New Smyrna is a member of Adventist Health System, a faith-based health care organization with 45 hospital campuses and 8,200 licensed beds in nine states, serving more than 5 million patients annually. With a mission to extend the healing ministry of Christ, Florida Hospital New Smyrna has 112-beds and is one of the seven Florida Hospitals in Flagler, Lake and Volusia counties that composes the Florida Hospital Central Florida Division - North Region. As the largest hospital system in the area, the Florida Hospital Central Florida Division - North Region has 1,226 beds and more than 7,800 employees. For more information about Florida Hospital New Smyrna, visit www.FHNewSmyrna.org.
Photo Caption:
Pictured from left to right: Pat Driver, Florida Hospital New Smyrna Foundation Chair, Jean Tauber, Florida Hospital New Smyrna Foundation board member, and Lilli Sheller, Best Western director of sales and marketing.
Recent News
-
Our Communities
UChicago Medicine AdventHealth team members and physicians provided health screenings, medical services and community connections at the Glendale Heights mission clinic.
-
Our Communities
A state-of-the-art hospital that will offer leading-edge treatments to patients from Central Florida and around the globe is coming to Lake Nona in Central Florida.
-
Our Communities
A new way of treating bladder cancer is revolutionizing the field. AdventHealth Cancer Institute is the only site in Florida and first in the U.S. to open this treatment via a trial.
